We collected and analyzed efgartigimod alfa-related reports from the FAERS database from the first quarter of 2022 through the second quarter of 2024. Disproportionality analysis was used in data mini
*AE = Adverse Event; a = the number of reports involving the drug of interest j and adverse event of interest i combination; b = reports of adverse event of interest i observed with other drugs; c = r
**Overview** The FDA Adverse Event Reporting System (FAERS) data package contains information on medication errors, quality complaints and drug related adverse events that were submitted to FDA in 20
The FEARS datasets include adverse drug events for mulitpe periods. The FDA released the datasets publicly. More information can be seen in the website of FDA:https://open.fda.gov/data/faers/
